Emergent Biosolutions Current Valuation vs. Net Income
| EBS Stock | USD 10.95 0.02 0.18% |
For Emergent Biosolutions profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Emergent Biosolutions to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Emergent Biosolutions utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Emergent Biosolutions's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Emergent Biosolutions over time as well as its relative position and ranking within its peers.
Emergent Biosolutions' Revenue Breakdown by Earning Segment
Check out Investing Opportunities.
Emergent Biosolutions Revenue Breakdown by Earning Segment
By analyzing Emergent Biosolutions' earnings estimates, investors can diagnose different trends across Emergent Biosolutions' analyst sentiment over time as well as compare current estimates against different timeframes.
Is there potential for Biotechnology market expansion? Will Emergent introduce new products? Factors like these will boost the valuation of Emergent Biosolutions. Projected growth potential of Emergent fundamentally drives upward valuation adjustments. Understanding fair value requires weighing current performance against future potential. All the valuation information about Emergent Biosolutions listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.56) | Earnings Share 1.32 | Revenue Per Share | Quarterly Revenue Growth (0.21) | Return On Assets |
Emergent Biosolutions's market price often diverges from its book value, the accounting figure shown on Emergent's balance sheet. Smart investors calculate Emergent Biosolutions' intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Since Emergent Biosolutions' trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
It's important to distinguish between Emergent Biosolutions' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Emergent Biosolutions should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. However, Emergent Biosolutions' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Emergent Biosolutions Net Income vs. Current Valuation Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Emergent Biosolutions's current stock value. Our valuation model uses many indicators to compare Emergent Biosolutions value to that of its competitors to determine the firm's financial worth. Emergent Biosolutions is rated # 2 in current valuation category among its peers. It is rated below average in net income category among its peers . At this time, Emergent Biosolutions' Net Loss is comparatively stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Emergent Biosolutions by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Emergent Current Valuation vs. Competition
Emergent Biosolutions is rated # 2 in current valuation category among its peers. After adjusting for long-term liabilities, total market size of Health Care industry is currently estimated at about 7.15 Billion. Emergent Biosolutions retains roughly 890.8 Million in current valuation claiming about 12% of equities under Health Care industry.
Emergent Net Income vs. Current Valuation
Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Emergent Biosolutions |
| = | 890.8 M |
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Emergent Biosolutions |
| = | (190.6 M) |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
Emergent Net Income Comparison
Emergent Biosolutions is currently under evaluation in net income category among its peers.
Emergent Biosolutions Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Emergent Biosolutions, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Emergent Biosolutions will eventually generate negative long term returns. The profitability progress is the general direction of Emergent Biosolutions' change in net profit over the period of time. It can combine multiple indicators of Emergent Biosolutions, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | -4.7 M | -4.9 M | |
| Operating Income | -97.8 M | -92.9 M | |
| Income Before Tax | -128.6 M | -122.2 M | |
| Total Other Income Expense Net | -30.8 M | -29.2 M | |
| Net Loss | -171.5 M | -163 M | |
| Income Tax Expense | 54.9 M | 57.6 M | |
| Net Loss | -171.5 M | -163 M | |
| Net Loss | -171.5 M | -163 M | |
| Non Operating Income Net Other | -10.5 M | -10 M | |
| Interest Income | 81.7 M | 85.7 M | |
| Net Interest Income | -63.9 M | -60.7 M | |
| Change To Netincome | 48.1 M | 44.4 M | |
| Net Loss | (4.14) | (3.93) | |
| Income Quality | (0.35) | (0.34) | |
| Net Income Per E B T | 1.20 | 1.26 |
Emergent Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Emergent Biosolutions. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Emergent Biosolutions position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Emergent Biosolutions' important profitability drivers and their relationship over time.
Emergent Biosolutions Earnings per Share Projection vs Actual
Use Emergent Biosolutions in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Emergent Biosolutions position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Emergent Biosolutions will appreciate offsetting losses from the drop in the long position's value.Emergent Biosolutions Pair Trading
Emergent Biosolutions Pair Trading Analysis
The ability to find closely correlated positions to Emergent Biosolutions could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Emergent Biosolutions when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Emergent Biosolutions - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Emergent Biosolutions to buy it.
The correlation of Emergent Biosolutions is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Emergent Biosolutions moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Emergent Biosolutions moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Emergent Biosolutions can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Emergent Biosolutions position
In addition to having Emergent Biosolutions in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Hotels Thematic Idea Now
Hotels
Hotels, inns, motels, and other companies providing lodging and hospitality services. The Hotels theme has 44 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Hotels Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Emergent Stock Analysis
When running Emergent Biosolutions' price analysis, check to measure Emergent Biosolutions' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Emergent Biosolutions is operating at the current time. Most of Emergent Biosolutions' value examination focuses on studying past and present price action to predict the probability of Emergent Biosolutions' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Emergent Biosolutions' price. Additionally, you may evaluate how the addition of Emergent Biosolutions to your portfolios can decrease your overall portfolio volatility.